Pharmaceutical development and specification of stereoisomers-Reference-Cited by-同舟云学术

Pharmaceutical development and specification of stereoisomers

Published:1998-09 Issue:6-7 Volume:17 Page:917-924
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Williams Reed C.,Riley Christopher M.,Sigvardson Kenneth W.,Fortunak Joseph,Ma Phillip,Nicolas Edgar C.,Unger Steven E.,Krahn David F.,Bremner Stephen L.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference17 articles.

1. Chromatographic Enantioseparation: Methods and Applications;Allenmark,1991

2. Separation of drug enantiomers by HPLC using chiral stationary phases — A selective review

3. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview

4. Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls

5. FDA Policy Statement for the Development of new Stereoisomer Drugs, Chirality 4, (1992) 3238–340.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chiral methods;Specification of Drug Substances and Products;2020

2. Mechanism of Reductive Metabolism and Chiral Inversion of Proton Pump Inhibitors;Drug Metabolism and Disposition;2019-04-08

3. Chiral separation of a basic drug with two chiral centers by electrokinetic chromatography for its pharmaceutical development;Journal of Chromatography A;2016-10

4. Part 3: Designation and Justification of API Starting Materials: Proposed Framework for Alignment from an Industry Perspective;Organic Process Research & Development;2015-06-15

5. Chiral methods;Specification of Drug Substances and Products;2014